Angiotensin-II Receptor Blockers (ARB): Revision history

From Glioblastoma Treatments
Jump to navigationJump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

12 November 2024

27 March 2024

25 March 2024

24 March 2024

  • curprev 05:2705:27, 24 March 2024‎ Lazy talk contribs‎ 1,232 bytes +1,232‎ Created page with "{{TreatmentInfo |drug_name=Angiotensin-II Receptor Blockers (ARB) |FDA_approval=Yes (for hypertension; repurposed for cancer studies) |used_for=Investigational use in glioblastoma for potential reduction of vasogenic edema and steroid-sparing effects |clinical_trial_phase=Retrospective Studies |common_side_effects=Varies by specific ARB; can include dizziness, hypotension, and renal function alteration |OS_with=Not specified; studies have focused on steroid requirements..."
Retrieved from "http://glioblastomatreatments.wiki:80/index.php?title=Angiotensin-II_Receptor_Blockers_(ARB)"